News Health & Medicine

What we still don’t know about Wegovy’s effect on strokes and heart attacks

Clinical trial results have ignited interest in the weight loss drug’s cardiovascular benefits

Three different retail packages of wegovy are displayed on a table using a narrow focus setting, so that only the middle package is in focus.

New clinical trial results suggest that the drug Wegovy may offer benefits beyond weight loss. In overweight and obese people without diabetes, treatment could also improve cardiovascular health.

Steffen Trumpf/picture-alliance/dpa/AP Images

By Meghan Rosen

A diabetes-turned-weight-loss medication could be on the verge of scoring a hat trick: It may also be a cardiovascular wonder drug.